Aller au contenu
warning sign

Pedestrian Crossing - Unsignalised

Most pedestrian crashes occur while the pedestrian is attempting to cross the road. A range of treatments can help pedestrians to cross safely, including the use of formal crossing points.

Unsignalised pedestrian crossings typically consist of signs and painted road markings (‘zebra crossings’).

Pedestrians are meant to have right of way over vehicles, but in many regions drivers do not stop for pedestrians. If this happens, unsignalised pedestrian crossings have few benefits and may actually be a hazard. These crossings are only suitable in situations with low traffic volumes and speeds.

Unsignalised pedestrian crossings may be unmarked and do not consist of strip markings. Pedestrians do not have priority and decide when it is safe to cross. The advantage is no delay to vehicles and only minor delay for pedestrians at light to moderate traffic volume. However, collisions could happen if pedestrians misjudge a safe gap while drivers do not expect to stop. Visually or mobility impaired pedestrians may also find it difficult to use these crossings.

Unsignalised pedestrian crossings may incorporate a raised feature (raised crossing) designed to slow the speed of approaching vehicles. The presence of such features should be clearly marked and advance warning provided. Various other safety devices can be included at crossings to improve safety, including traffic calming, refuge islands, advanced warning signs and pavement markings, street lighting, and flashing lights.

In all circumstances, unsignalised crossings should be highly conspicuous and visible to approach drivers. It is always desirable to reduce traffic speed on the approach and through the crossing area.

le Démonstrateur de classement par étoiles est un outil disponible gratuitement avec le logiciel en ligne iRAP, ViDA. Avec le Démonstrateur de classement par étoiles, il est possible d'explorer l'impact que ce traitement des routes plus sûres a sur le risque.

Treatment Summary

Costs

Low

Treatment life

1 year - 5 years

Effectiveness

25-40%

Études de cas

Aucune étude de cas connexe à ce stade

Images connexes

LinkedIn
Share
French
Powered by TranslatePress »